ZNF429
Zinc finger protein 429
Also known as: ZN429_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q86V71
- Gene
- ZNF429
- Ensembl
- ENSG00000197013
- Chromosome
- 19
- Canonical length
- 674 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
674 residues, UniProt reviewed canonical sequence.
>Q86V71|ZNF429
1 MGPLTFTDVA IEFSLEEWQC LDTAQQNLYR NVMLENYRNL VFLGIAVSKP DLITCLEKEK
61 EPCKMKRHEM VDEPPVVCSH FAEDFWPEQD IKDSFQKVTL RRYDKRGHEN LQLRKGYKTV
121 GDCKLYKGGY NGLNQCLTLT QSKMYHCDIY VKVFYAFSNA DRYKTRHTGK KPFQCKKCGK
181 SFCMLSQLTQ HKKIHIRENT YRCKEFGNAF NQSSALTNHK RIYVGEKHYR CEECGKAFNH
241 YSTLTNHKRI HTGEKPYKCK ECGKAFSRYS TLTTHKRIHS GEKPYKCDEC GKTFSISSTF
301 TKHKIIHTEE KPYKCKECGK AFNRSSTLTS HKRIHTGEKP YKCEECGKAF NWSSTLTKHK
361 VIHTGEKPYK CEECGKAFNQ SSRLTRHKKI HTGEEPYKFE KCGRVFTCSS TLTQDKKIHT
421 GEKPYNCEEC GKVFTYSSTL TRHKRIHTEE KPYKCNECGK AFNRSSHLTS HRRIHTGEKP
481 YKCEECGKAF KQSSNLNSHK KIHSGEKPYK CEECGKAFIL SSRLTQHKKI HTGEKPYKCE
541 ECGKAFNRSS RLTQHKKIHT GEKPYKCKQC DKAFTHSSNL SSHKKIHSGE KPYKCEECGK
601 AFNRSSRLTQ HKKIHTREKP YKCEECAKAF TRSSRLTQHK KIHRMGVVAH ACNPSTLGGR
661 GGRITRSGDR DRPGLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ZNF429 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.44
- Highest tissue expression
- 7.2 nTPM
Expression across tissuesHPA
Tissue
- thyroid gland: 7.2 nTPM
- skin: 6 nTPM
- epididymis: 5.6 nTPM
- ovary: 5.6 nTPM
- spleen: 5.4 nTPM
- thymus: 5.3 nTPM
Single-cell type
- neutrophils: 490 nCPM
- choroid plexus epithelial cells: 89 nCPM
- thyrotrophs: 73 nCPM
- adipocytes: 72 nCPM
- tuft cells: 69 nCPM
- adrenal cortex cells: 67 nCPM
Immune cell
- basophil: 6.3 nTPM
- neutrophil: 5.6 nTPM
- NK-cell: 4.6 nTPM
- naive CD4 T-cell: 4.5 nTPM
- naive CD8 T-cell: 4.3 nTPM
- eosinophil: 4.2 nTPM
Brain region
- cerebellum: 37 nTPM
- white matter: 35 nTPM
- cerebral cortex: 34 nTPM
- amygdala: 33 nTPM
- basal ganglia: 32 nTPM
- choroid plexus: 32 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.89
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.99
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- negative regulation of transcription by RNA polymerase II
- regulation of transcription by RNA polymerase II
Molecular functions
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ZNF429 as an antibody target. Whether an autoantibody or antibody against ZNF429 could matter depends on whether native ZNF429 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ZNF429 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ZNF429 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...